AAAAAA
Results:
1-25
|
Results: 25
Authors:
Becker, E
Richardson, DR
Citation: E. Becker et Dr. Richardson, Frataxin: its role in iron metabolism and the pathogenesis of Friedreich'sataxia, INT J BIO C, 33(1), 2001, pp. 1-10
Authors:
Green, DA
Antholine, WE
Wong, SJ
Richardson, DR
Chitambar, CR
Citation: Da. Green et al., Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: Effect on the R2 subunit of ribonucleotide reductase, CLIN CANC R, 7(11), 2001, pp. 3574-3579
Authors:
Bernhardt, PV
Chin, P
Richardson, DR
Citation: Pv. Bernhardt et al., Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy, J BIOL I CH, 6(8), 2001, pp. 801-809
Authors:
Richardson, DR
Mouralian, C
Ponka, P
Becker, E
Citation: Dr. Richardson et al., Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron, BBA-MOL BAS, 1536(2-3), 2001, pp. 133-140
Authors:
Richardson, DR
Citation: Dr. Richardson, Iron and gallium increase iron uptake from transferrin by human melanoma cells: further examination of the ferric ammonium citrate-activated iron uptake process, BBA-MOL BAS, 1536(1), 2001, pp. 43-54
Authors:
Richardson, DR
Dean, RT
Citation: Dr. Richardson et Rt. Dean, Does free extracellular iron exist in haemochromatosis and other pathologies, and is it redox active?, CLIN SCI, 100(3), 2001, pp. 237-238
Authors:
Richardson, DR
Citation: Dr. Richardson, The controversial role of deferiprone in the treatment of thalassemia, J LA CL MED, 137(5), 2001, pp. 324-329
Authors:
Thomas, SR
Salahifar, H
Mashima, R
Hunt, NH
Richardson, DR
Stocker, R
Citation: Sr. Thomas et al., Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: Posttranslational regulation by pyrrolidine dithiocarbamate, J IMMUNOL, 166(10), 2001, pp. 6332-6340
Authors:
Watts, RN
Richardson, DR
Citation: Rn. Watts et Dr. Richardson, Nitrogen monoxide (NO) and glucose - Unexpected links between energy metabolism and NO-mediated iron mobilization from cells, J BIOL CHEM, 276(7), 2001, pp. 4724-4732
Authors:
Gao, J
Richardson, DR
Citation: J. Gao et Dr. Richardson, The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression, BLOOD, 98(3), 2001, pp. 842-850
Authors:
Lovejoy, DB
Richardson, DR
Citation: Db. Lovejoy et Dr. Richardson, Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia, EXPERT OP I, 9(6), 2000, pp. 1257-1270
Authors:
Lovejoy, DB
Richardson, DR
Bernhardt, PV
Citation: Db. Lovejoy et al., 2-Hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone, ACT CRYST C, 56, 2000, pp. 341-342
Authors:
Watts, RN
Richardson, DR
Citation: Rn. Watts et Dr. Richardson, Examination of the mechanism of action of nitrogen monoxide on iron uptakefrom transferrin, J LA CL MED, 136(2), 2000, pp. 149-156
Authors:
Sekyere, E
Richardson, DR
Citation: E. Sekyere et Dr. Richardson, The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport?, FEBS LETTER, 483(1), 2000, pp. 11-16
Authors:
Richardson, DR
Citation: Dr. Richardson, The role of the membrane-bound tumour antigen, melanotransferrin (p97), iniron uptake by the human malignant melanoma cell, EUR J BIOCH, 267(5), 2000, pp. 1290-1298
Authors:
Wardrop, SL
Richardson, DR
Citation: Sl. Wardrop et Dr. Richardson, Interferon-gamma and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages, EUR J BIOCH, 267(22), 2000, pp. 6586-6593
Authors:
Wardrop, SL
Watts, RN
Richardson, DR
Citation: Sl. Wardrop et al., Nitrogen monoxide activates iron regulatory protein 1 RNA-binding activityby two possible mechanisms: Effect on the [4Fe-4S] cluster and iron mobilization from cells, BIOCHEM, 39(10), 2000, pp. 2748-2758
Authors:
Richardson, DR
Bernhardt, PV
Citation: Dr. Richardson et Pv. Bernhardt, Crystal and molecular structure of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: an iron chelator with anti-tumour activity, J BIOL I CH, 4(3), 1999, pp. 266-273
Authors:
Richardson, DR
Becker, E
Bernhardt, PV
Citation: Dr. Richardson et al., The biologically active iron chelators 2-pyridylcarboxaldehyde isonicotinoylhydrazone, 2-pyridylcarboxaldehyde benzoylhydrazone monohydrate and 2-furaldehyde isonicotinoylhydrazone, ACT CRYST C, 55, 1999, pp. 2102-2105
Authors:
Richardson, DR
Green, LR
Citation: Dr. Richardson et Lr. Green, Social sanction and threat explanations of gender effects on direct and indirect aggression, AGGR BEHAV, 25(6), 1999, pp. 425-434
Authors:
Richardson, DR
Citation: Dr. Richardson, Role of ceruloplasmin and ascorbate in cellular iron release, J LA CL MED, 134(5), 1999, pp. 454-465
Authors:
Becker, E
Richardson, DR
Citation: E. Becker et Dr. Richardson, Development of novel aroylhydrazone ligands for iron chelation therapy: 2-Pyridylcarboxaldehyde isonicotinoyl hydrazone analogs, J LA CL MED, 134(5), 1999, pp. 510-521
Authors:
Richardson, DR
Chua, ACG
Baker, E
Citation: Dr. Richardson et al., Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: Implications for the pathogenesis ofiron-overload disease, J LA CL MED, 133(2), 1999, pp. 144-151
Authors:
Wardrop, SL
Richardson, DR
Citation: Sl. Wardrop et Dr. Richardson, The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake, EUR J BIOCH, 263(1), 1999, pp. 41-49
Authors:
Darnell, G
Richardson, DR
Citation: G. Darnell et Dr. Richardson, The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: The effect of the ligands on molecular targets involved in proliferation, BLOOD, 94(2), 1999, pp. 781-792
Risultati:
1-25
|